https://www.selleckchem.com/pr....oducts/belvarafenib.
or greater TR at 6 weeks (0.2 ± 0.4 vs 1.25 ± 0.5; P = .03). CorMatrix anterior leaflet augmentation produces successful, stable repair in the majority of this complex population. The presence of even mild TR at 6 weeks' follow-up predicts a poor result. When the tethering area or the tethering distance is significantly high, replacement is probably a better option. CorMatrix anterior leaflet augmentation produces successful, stable repair in the majority of this complex population. The presence of even mild TR at 6 weeks' follow-u